<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ind Microbiol Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">J Ind Microbiol Biotechnol</journal-id><journal-id journal-id-type="publisher-id">jimb</journal-id><journal-title-group><journal-title>Journal of Industrial Microbiology &#x00026; Biotechnology</journal-title></journal-title-group><issn pub-type="ppub">1367-5435</issn><issn pub-type="epub">1476-5535</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8788812</article-id><article-id pub-id-type="pmid">34402899</article-id><article-id pub-id-type="doi">10.1093/jimb/kuab059</article-id><article-id pub-id-type="publisher-id">kuab059</article-id><article-categories><subj-group subj-group-type="heading"><subject>Biotechnology Methods</subject><subj-group subj-group-type="category-toc-heading"><subject>Review</subject></subj-group></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI01150</subject><subject>AcademicSubjects/SCI00540</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>Jimb/3</subject></subj-group></article-categories><title-group><article-title>Basic and applied research on multiple aminoglycoside antibiotic resistance of actinomycetes: an old-timer's recollection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hotta</surname><given-names>Kunimoto</given-names></name><!--khotta@fwf.or.jp--><aff>
<institution>Functional Water Foundation</institution>, <addr-line>2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141-0021</addr-line>, <country country="JP">Japan</country></aff><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="cor1">Correspondence should be addressed to: E-mail: <email>khotta@fwf.or.jp</email></corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2021</year></pub-date><pub-date pub-type="epub" iso-8601-date="2021-08-17"><day>17</day><month>8</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>8</month><year>2021</year></pub-date><volume>48</volume><issue>9-10</issue><elocation-id>kuab059</elocation-id><history><date date-type="received"><day>13</day><month>5</month><year>2021</year></date><date date-type="accepted"><day>03</day><month>8</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021. Published by Oxford University Press on behalf of Society of Industrial Microbiology and Biotechnology.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p></license></permissions><self-uri xlink:href="kuab059.pdf"/><abstract><title>Abstract</title><p>A list of our research achievements on multiple aminoglycoside antibiotic (AG) resistance in AG-producing actinomycetes is outlined. In 1979, the author discovered a novel AG (istamycin)-producing <italic toggle="yes">Streptomyces tenjimariensis</italic> SS-939 by screening actinomycetes with kanamycin (KM)-resistance and plasmid profiles. This discovery directed our biochemical and genetic approaches to multiple AG resistance (AGR) of AG producers. In this article, the following discoveries will be outlined: (1) AGR profiles correlating with the productivity of AGs in AG-producers, (2) Wide distribution of multiple AG resistance in AG-nonproducing actinomycetes, (3) Involvement of ribosomal resistance and AG-acetylating enzymes as underlying AGR factors, (4) Activation by single nucleotide substitution of a silent gene coding for aminoglycoside 3-<italic toggle="yes">N-</italic>acetyltransferase, AAC(3), in <italic toggle="yes">S. griseus</italic>, (5) Discovery of a novel antibiotic indolizomycin through protoplast fusion treatment between <italic toggle="yes">S. tenjimariensis</italic> and <italic toggle="yes">S. griseus</italic> strains with different AGR phenotypes, and (6) Double stage-acting activity of arbekacin (ABK; an anti-MRSA semisynthetic AG) discovered by acetylation of ABK with cloned AACs; that is both ABK and its acetylated derivatives showed remarkable antibiotic activities.</p></abstract><kwd-group kwd-group-type="keywords"><kwd>Actinomycetes</kwd><kwd>Multiple aminoglycoside antibiotic resistance</kwd><kwd>Gene activation</kwd><kwd>Double stage-acting activity</kwd><kwd>Plasmid profile screening</kwd></kwd-group><counts><page-count count="8"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Antibiotic resistance in actinomycetes has been investigated from various perspectives such as self-resistance (Cundliffe, <xref rid="bib2" ref-type="bibr">1989</xref>; Demain, <xref rid="bib3" ref-type="bibr">1974</xref>), involvement in antibiotic biosynthesis (Piepersberg &#x00026; Distler, <xref rid="bib32" ref-type="bibr">1997</xref>; Hotta et al., <xref rid="bib12" ref-type="bibr">1995</xref>), origin of clinical antibiotic resistance (Benveniste &#x00026; Davies, <xref rid="bib1" ref-type="bibr">1973</xref>), and distribution among actinomycetes (Hotta et al., <xref rid="bib8" ref-type="bibr">1983a</xref>). In the 1970s, the author and colleagues started investigations into the self-resistance of AG-producing <italic toggle="yes">Streptomyces</italic> strains (Hotta &#x00026; Okami, <xref rid="bib5" ref-type="bibr">1976</xref>) and the screening of actinomycete isolates for plasmids since plasmid involvement in antibiotic biosynthesis was a leading topic at that time (Okanishi, <xref rid="bib30" ref-type="bibr">1979</xref>). Consequently, we discovered <italic toggle="yes">Streptomyces tenjimariensis</italic> SS-939 that produced istamycins (ISMs) as a new astromicin (ASTM) group of AGs (Hotta et al., <xref rid="bib6" ref-type="bibr">1980</xref>; Okami et al., <xref rid="bib29" ref-type="bibr">1979</xref>) and possessed a novel plasmid profile (Shigyo et al., <xref rid="bib34" ref-type="bibr">1984</xref>). However, the production of KM-group AGs could not be detected despite the isolated strain being KM resistant. Thereafter, we examined its resistance to foreign AGs. It turned out that this strain exhibited multiple AGR that could not be explained by the substrate specificity of any of the known AG-inactivating enzymes. Subsequent biochemical characterization revealed that the resistance factor involved ribosomes with novel resistance specificity (Yamamoto et al., <xref rid="bib38" ref-type="bibr">1981a</xref>, <xref rid="bib39" ref-type="bibr">1981b</xref>). Consequently, we expanded the characterization of other AG producers (Hotta et al., <xref rid="bib7" ref-type="bibr">1981</xref>; Yamamoto et al., <xref rid="bib40" ref-type="bibr">1982</xref>) and demonstrated the existence of individual AGR profiles correlating with the productivity of their own AGs (Hotta et al., <xref rid="bib9" ref-type="bibr">1983b</xref>). The discovered AGR phenotypes were mainly dependent on the functions of self-resistance factors such as AG-modifying enzymes and ribosomes. In some cases, however, additional factors that do not contribute to self-resistance were found to exist (Hotta et al., <xref rid="bib11" ref-type="bibr">1992</xref>; Hotta &#x00026; Okami, <xref rid="bib13" ref-type="bibr">1996</xref>). These included AACs of <italic toggle="yes">S. griseus</italic> (Hotta et al., <xref rid="bib10" ref-type="bibr">1988</xref>), <italic toggle="yes">S. kasugaensis</italic> (Hotta et al., <xref rid="bib14" ref-type="bibr">1996a</xref>, <xref rid="bib15" ref-type="bibr">1996b</xref>) and an unidentified actinomycete strain #8 (Zhu et al., <xref rid="bib43" ref-type="bibr">1999</xref>) that produced streptomycin (SM), kasugamycin (KSM) but no AG, respectively. These AACs were eventually characterized for substrate specificity as well as gene structure.</p><p>The above findings stimulated the idea that it might be possible to obtain new results if we were successful in creating novel AGR by manipulation of AG-producing strains. We challenged an interspecies protoplast fusion using strains of <italic toggle="yes">S. tenjimariensis</italic> and <italic toggle="yes">S. griseus</italic>, taking advantage of their reciprocal resistance to KM and SM. Consequently, this challenge resulted in the emergence of indolizomycin (a novel antibiotic)-producing strain (Gomi et al., <xref rid="bib4" ref-type="bibr">1984</xref>; Yamashita et al., <xref rid="bib41" ref-type="bibr">1985a</xref>). Protoplast regeneration was then carried out and this resulted in the emergence of KM resistance (Yamashita et al., <xref rid="bib42" ref-type="bibr">1985b</xref>) specifically in <italic toggle="yes">S. griseus.</italic></p><p>On the other hand, the above AACs were used for simulative investigations on the possible emergence of AAC-dependent resistance to an anti-MRSA (methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>) agent shown to be refractory to AACs of clinical origin. arbekacin (ABK) that has been (Kondo &#x00026; Hotta, <xref rid="bib25" ref-type="bibr">1999</xref>). It turned out that ABK was readily acetylated but the acetylated ABK derivatives retained antibiotic activity. This indicated double stage activity of ABK and pointed to the remote possibility of generating of AAC-dependent ABK-resistant MRSA.</p><p>In this article, these achievements are outlined.</p><sec id="sec1-1"><title>AG Resistance Profiles: Specificity and Diversity</title><p>Table&#x000a0;<xref rid="tbl1" ref-type="table">1</xref> shows AGR profiles of AG producers and other strains. AG producers exhibited specific AGR profiles. All were reproducible in terms of the different strains of AG producers examined (Hotta et al., <xref rid="bib9" ref-type="bibr">1983b</xref>). It was conclusively shown that the AG producers demonstrate individual multiple AGR profiles except for <italic toggle="yes">S. griseus</italic> SS-1198. This strain was resistant to only its own AG (SM) and contained a hidden AG resistance factor that was activated by protoplast regeneration treatment (Yamashita et al., <xref rid="bib42" ref-type="bibr">1985b</xref>). Interestingly, the strain designated SS-1198PR emerged with additional resistance to KM and GM (gentamicin).</p><table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Profiles and Biochemical Basis of Multiple AG Resistance in Actinomycetes</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th align="center" colspan="8" rowspan="1">AG resistance<xref rid="tb1fn1" ref-type="table-fn">*</xref></th><th align="center" colspan="2" rowspan="1">Resistance factor</th></tr><tr><th align="left" rowspan="1" colspan="1">Strains</th><th align="left" rowspan="1" colspan="1">Own AGs</th><th align="left" rowspan="1" colspan="1">S</th><th align="left" rowspan="1" colspan="1">K</th><th align="left" rowspan="1" colspan="1">G</th><th align="left" rowspan="1" colspan="1">R</th><th align="left" rowspan="1" colspan="1">B</th><th align="left" rowspan="1" colspan="1">N</th><th align="left" rowspan="1" colspan="1">P</th><th align="left" rowspan="1" colspan="1">I</th><th align="left" rowspan="1" colspan="1">Self</th><th align="left" rowspan="1" colspan="1">Nonself</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"> Streptomyces <italic toggle="yes">tenebrarius</italic> ISP5477</td><td rowspan="1" colspan="1">TOB</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"> 16SrRNA, AAC(2&#x02032;), AAC(6&#x02032;)</td><td rowspan="1" colspan="1"> APH(6)</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces kasugaensis</italic> MB273</td><td rowspan="1" colspan="1">KSM</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cb;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">AAC</td><td rowspan="1" colspan="1">AAC(2&#x02032;)</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces tenjimariensis</italic> SS-939</td><td rowspan="1" colspan="1">ISM</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">16SrRNA</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces kanamyceticus</italic> ISP5500</td><td rowspan="1" colspan="1">KM</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">AAC(6&#x02032;), 16SrRNA(?)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces fradiae</italic> ISP5063</td><td rowspan="1" colspan="1">NM</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cb;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cb;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">APH(3&#x02032;), AAC(3)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Micromonospora <italic toggle="yes">purpurea</italic> KCC-0074</td><td rowspan="1" colspan="1">GM</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">16SrRNA</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces griseus</italic> SS-1198</td><td rowspan="1" colspan="1">SM</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">APH(6)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">SS-1198PR</td><td rowspan="1" colspan="1">&#x02212;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cb;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cb;</td><td rowspan="1" colspan="1">&#x025cb;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">APH(6)</td><td rowspan="1" colspan="1">AAC(3)</td></tr><tr><td rowspan="1" colspan="1">Strain #8</td><td rowspan="1" colspan="1">?</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x025cf;</td><td rowspan="1" colspan="1">?</td><td rowspan="1" colspan="1">AAC(1), AAC(6&#x02032;)</td></tr></tbody></table><table-wrap-foot><fn id="tb1fn1"><p>*Resistance to 50&#x000a0;&#x000b5;g/ml of AG; &#x025cf;: resistant, &#x025cb;: variable, No indication: sensitive. S &#x00026; SM: streptomycin, K &#x00026; KM: kanamycin, G &#x00026; GM: gentamicin, R: ribostamycin, B: butirocin, N &#x00026; NM: neomycin, P: paromomycin, I &#x00026; ISM: istamycin, TOB: tobramycin, KSM: kasugamycin, AAC: aminoglycoside <italic toggle="yes">N</italic>-acetyltransferase, APH: aminoglycoside <italic toggle="yes">O</italic>-phosphotransferase.</p></fn></table-wrap-foot></table-wrap><p>Furthermore, to check the incidence of multiple AGR (Hotta et al., <xref rid="bib8" ref-type="bibr">1983a</xref>), we isolated many soil actinomycete strains using an agar medium (ISP No. 4) supplemented with (20&#x000a0;&#x003bc;g/ml) or without one of the following AGs; SM, KM, DKB (dibekacin), GM, RSM (ribostamycin), BT (butirocin), NM (neomycin), PRM (paromomycin), and LVM (lividomycin). It turned out that isolates isolated from AG-containing plates showed wide varieties of multiple AGR, whereas the majority of isolates on AG-free plates showed resistance to none or only a few AGs. As a whole, we confirmed over 150 distinct multiple AGR profiles among about 500 isolates. It was notable that isolates from AG-containing plates provided producers of SM, ISM (istamycin), NM, RSM, GM, PRM, Trehalosamine, and SPCM (spectinomycin), whereas only SM-producing isolates were included among isolates from AG-free plates. It was thereby indicative that in order to obtain novel AG-producing organism, it would be advantageous to screen those with multiple AGR (Takahashi et al., <xref rid="bib37" ref-type="bibr">1986</xref>). It was also notable that multiple AGR isolates included rare actinomycetes: for example, <italic toggle="yes">Crossiella cryophile</italic> (Labeda, <xref rid="bib26" ref-type="bibr">2001</xref>) that was initially classified as <italic toggle="yes">Nocardiopsis mutabilis</italic> (Takahashi et al., 1986) which produced the novel antibiotic, dopsisamine.</p><p>During the characterization of AGR, we were aware that semisynthetic AGs such as ABK inhibited wide varieties of strains with multiple AGR. In this context, strain #8 (isolated as an ABK resistant) was remarkable in that its multiple AGR included NM, but not PRM (as shown in Table&#x000a0;<xref rid="tbl1" ref-type="table">1</xref>). Cross resistance between NM and PRM has been generally known in clinically occurring AG-resistant bacteria. Strain #8 was not identified taxonomically but exhibited properties of <italic toggle="yes">Amycolatopsis</italic>.</p></sec><sec id="sec1-2"><title>Biochemical and Genetic Factors Underlying Multiple AGRs of AG Producers</title><p>Multiple AGR in AG producers are mainly dependent on self-resistance factors such as ribosomes and/or AG-modifying enzymes as summarized in Table&#x000a0;<xref rid="tbl1" ref-type="table">1</xref>. For example, the multiple AGR profile of ISM-producing <italic toggle="yes">S. tenjimariensis</italic> SS-939 is due to ribosomal AGR specificity (Yamamoto et al., <xref rid="bib38" ref-type="bibr">1981a</xref>, <xref rid="bib39" ref-type="bibr">1981b</xref>). In cases of producers of TOB (tobramycin) and KM, both ribosomes and the substrate specificity of AAC(6&#x02032;) are involved (Hotta et al., <xref rid="bib7" ref-type="bibr">1981</xref>; Yamamoto et al., <xref rid="bib40" ref-type="bibr">1982</xref>). In cases of NM and SM producers, AG-inactivating enzymes such as AAC and APH (aminoglycoside-<italic toggle="yes">O</italic>-phosphotransferase) are involved. On the other hand, additional factors such as APH(6) and AAC(2&#x02032;) turned out to contribute to multiple AGR in the producers of TOB (Yamamoto et al., <xref rid="bib40" ref-type="bibr">1982</xref>) and KSM (Hotta et al., <xref rid="bib14" ref-type="bibr">1996a</xref>), respectively. Furthermore, additional AGR emerged in <italic toggle="yes">S. griseus</italic> SS-1198PR and turned out to be due to an activated cryptic AAC(3). The factor(s) conferring multiple AGR on strain #8 (Zhu et al., <xref rid="bib43" ref-type="bibr">1999</xref>) were categorized as nonessential resistance factor since no AG productivity has (to date) been detected in this strain. However, we cloned an AAC(6&#x02032;) gene capable of conferring multiple AGR (Zhu et al., <xref rid="bib43" ref-type="bibr">1999</xref>) and detected AAC(1) activity (Sunada et al., <xref rid="bib36" ref-type="bibr">1999</xref>) using cell free extracts of strain #8. Based on these findings described above, we proposed &#x0201c;primary resistance&#x0201d; for self-resistance and &#x0201c;secondary resistance&#x0201d; for nonself-resistance (Hotta et al., <xref rid="bib11" ref-type="bibr">1992</xref>).</p></sec><sec id="sec1-3"><title>Characterization of Nonself-Resistance Factors</title><p>We characterized the biochemical basis for the activated AAC(3), AAC(2&#x02032;), and AAC(6&#x02032;) of <italic toggle="yes">S. griseus</italic> SS-1198PR, <italic toggle="yes">S. kasugaensis</italic> MB273 and strain #8, respectively. In the biochemical characterization, the author had a strong interest in whether these AACs were capable of acetylating and/or inactivating ABK (Hotta &#x00026; Kondo, <xref rid="bib19" ref-type="bibr">2017</xref>; Kondo &#x00026; Hotta, <xref rid="bib25" ref-type="bibr">1999</xref>) and ASTM (Nara et al., <xref rid="bib27" ref-type="bibr">1977</xref>) (refer to Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1</xref>). This is because these AACs were believed to be refractory to various known AG-modifying enzymes including AACs. ASTM (= fortimicin) is a natural AG approved in 1985 and ABK is a semisynthetic AG approved in 1990 in Japan (Kondo et al., <xref rid="bib24" ref-type="bibr">1991</xref>). In addition, their related AGs such as ISM-B and semisynthetic AGs were also examined.</p><fig position="float" id="fig1"><label>Fig. 1</label><caption><p>Structures of aminoglycoside antibiotics and enzymatic modification sites. Adapted from Hotta et al. (<xref rid="bib17" ref-type="bibr">2000</xref>).</p></caption><graphic xlink:href="kuab059fig1" position="float"/></fig><sec id="sec1-3-1"><title>AAC(3) emerged by activation of a silent gene in <italic toggle="yes">S. griseus</italic></title><p>The activated cryptic AAC(3) of <italic toggle="yes">S. griseus</italic> SS-1198PR was found and characterized. In general, SM-producing strains of <italic toggle="yes">S. griseus</italic> are highly resistant to SM but sensitive to KM. In <italic toggle="yes">S. griseus</italic> SS-1198, however, protoplast regeneration treatment (Yamashita et al., <xref rid="bib41" ref-type="bibr">1985a</xref>) resulted in the generation of clones with 100- to 200-fold increased KM resistance at a frequency of 10<sup>&#x02013;6</sup>. A DNA fragment (1.8&#x000a0;kb <italic toggle="yes">Bgl</italic>II-<italic toggle="yes">Bam</italic>HI) was cloned as the KM resistance gene (designated <italic toggle="yes">kan</italic>) into <italic toggle="yes">S. lividans</italic> TK21 from <italic toggle="yes">S. griseus</italic> SS-1198PR (Hotta et al., <xref rid="bib10" ref-type="bibr">1988</xref>). Subsequent biochemical characterization revealed that the KM resistance was due to AAC activity. Structure determination of the acetylation product of KM revealed the enzyme to be an AAC(3). Based on its substrate specificity, the enzyme was putatively designated AAC(3)-VI and later redesignated AAC(3)-Xa (Ishikawa et al., <xref rid="bib20" ref-type="bibr">1988</xref>; Shaw et al., <xref rid="bib33" ref-type="bibr">1993</xref>).</p><p>In order to clarify the underlying mechanism for the emergence of the KM resistance, the wild-type gene designated <italic toggle="yes">kan<sup>0</sup></italic> was cloned from strain SS-1198 using the <italic toggle="yes">kan</italic> gene as a probe (Hotta et al., <xref rid="bib11" ref-type="bibr">1992</xref>; Ishikawa et al., <xref rid="bib20" ref-type="bibr">1988</xref>). Comparison of the size and restriction map of the two 1.8-kb <italic toggle="yes">Bgl</italic>II-<italic toggle="yes">Bam</italic>HI fragments revealed no obvious difference. This indicated that a point mutation is responsible for the emergence of the high level of KM resistance in strain SS-1198PR (Ishikawa et al., <xref rid="bib23" ref-type="bibr">2000</xref>). Subsequent analysis of the above 1.8-kb <italic toggle="yes">Bgl</italic>II-<italic toggle="yes">Bam</italic>HI fragments by fragment exchange as well as nucleotide sequencing localized the mutation site to the -10 promoter region (Hotta et al., <xref rid="bib11" ref-type="bibr">1992</xref>; Ishikawa et al., <xref rid="bib20" ref-type="bibr">1988</xref>); one base substitution of T for C at the first letter of the -10 promoter sequence was found between the <italic toggle="yes">kan</italic> and <italic toggle="yes">kan<sup>0</sup></italic> genes (summarized in Table&#x000a0;<xref rid="tbl2" ref-type="table">2</xref>). We confirmed the enhanced level of mRNA in strain SS-1198PR as well as the enhanced transcription activity in <italic toggle="yes">kan</italic> gene (Ishikawa et al., <xref rid="bib20" ref-type="bibr">1988</xref>, <xref rid="bib23" ref-type="bibr">2000</xref>, Ishikawa &#x00026; Hotta, <xref rid="bib21" ref-type="bibr">1991</xref>). It was thus conclusive that these changes resulted in the KM hyperresistance of strain SS-1198PR.</p><table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>Correlation of <italic toggle="yes">kan</italic> Gene Activation with One Base Substitution at the -10 Promoter Region</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">
<italic toggle="yes">Streptomyces griseus</italic>
</th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">SS-1198</th><th align="left" rowspan="1" colspan="1">SS-1198PR</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<italic toggle="yes">Gene</italic>
</td><td rowspan="1" colspan="1">
<italic toggle="yes">kan<sup>0</sup></italic>
</td><td rowspan="1" colspan="1">
<italic toggle="yes">Kan</italic>
</td></tr><tr><td rowspan="1" colspan="1">-10 promoter sequence</td><td rowspan="1" colspan="1">CATGAT</td><td rowspan="1" colspan="1">TATGAT</td></tr><tr><td rowspan="1" colspan="1">Promoter activity</td><td rowspan="1" colspan="1">Weak</td><td rowspan="1" colspan="1">Strong</td></tr><tr><td rowspan="1" colspan="1">mRNA level</td><td rowspan="1" colspan="1"> Low</td><td rowspan="1" colspan="1">High</td></tr><tr><td rowspan="1" colspan="1">AAC(3) level</td><td rowspan="1" colspan="1"> Low</td><td rowspan="1" colspan="1">High</td></tr><tr><td rowspan="1" colspan="1">KM resistance</td><td rowspan="1" colspan="1">&#x0003c;5&#x000a0;&#x003bc;g/ml</td><td rowspan="1" colspan="1">1000&#x000a0;&#x003bc;g/ml</td></tr></tbody></table></table-wrap><p>The structure gene of the <italic toggle="yes">kan</italic> was identified as an 855&#x000a0;bp ORF (ATG as the start codon) that coded for a protein consisting of 284 amino acids (Ishikawa et al., <xref rid="bib23" ref-type="bibr">2000</xref>). The ORF showed high homology and similarity at the nucleotide and amino acid levels with those of the known AAC(3) enzymes; for example, the AAC(3) gene of a PRM-producer showed 76% and 85% matching identities at the nucleotide and amino acid levels (Ishikawa et al., <xref rid="bib23" ref-type="bibr">2000</xref>). In addition, DNA sequences homologous to the AAC(3) gene were found to exist in all strains of <italic toggle="yes">S. griseus</italic> tested (Ishikawa &#x00026; Hotta, <xref rid="bib21" ref-type="bibr">1991</xref>).</p><p>Characterization of substrate specificity later revealed that this AAC(3) was capable of acetylating ABK and AMK that had been believed to be refractory to AAC(3) of clinically significant bacteria (Hotta &#x00026; Kondo, <xref rid="bib19" ref-type="bibr">2017</xref>). It should be noted that the acetylation sites were 3&#x02032;-NH<sub>2</sub> for ABK and AMK (shown in Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1</xref>), whereas 3-NH<sub>2</sub> for KM (Hotta et al., <xref rid="bib16" ref-type="bibr">1998</xref>).</p></sec><sec id="sec1-3-2"><title>AAC(2&#x02032;) of <italic toggle="yes">S. kasugaensis</italic></title><p>Characterization of the AAC(2&#x02032;) of <italic toggle="yes">S. kasugaensis</italic> MB273 was carried out (Hotta et al., <xref rid="bib14" ref-type="bibr">1996a</xref>, <xref rid="bib15" ref-type="bibr">1996b</xref>). As shown in Table&#x000a0;<xref rid="tbl1" ref-type="table">1</xref>, this strain exhibited resistance to wide varieties of AGs and especially high levels of resistance (1&#x000a0;mg/ml) to ISM-B (an ASTM group AG) and RSM, but was otherwise sensitive to KM and GM. Modification experiments using cell free extracts revealed AAC dependence on multiple AGR. Since ASTM had been believed to be refractory to known AG-modifying enzymes, we carried out the cloning of the ISM-B resistance gene and followed up by characterizing the AAC encoded by the cloned gene. The ISM-B resistance gene, designated <italic toggle="yes">ist</italic>, was cloned as pANT12 containing a 6.5&#x000a0;kb (<italic toggle="yes">Bam</italic>HI-<italic toggle="yes">Sau</italic>3AI) DNA segment into <italic toggle="yes">S. lividans</italic> TK21. The cell free extract from <italic toggle="yes">S. lividans</italic> TK21/pANT12 was capable of acetylating RSM, ASTM, ISM-A, and ISM-B. The structure determination revealed that RSM, ASTM, and ISM-A were acetylated at 2&#x02032;-NH<sub>2</sub> indicating the involvement of AAC(2&#x02032;). In contrast, ISM-B (the 1-NH<sub>2</sub> epimer of ISM-A) was acetylated at 1-NH<sub>2</sub>. Since the configuration of 1-NH<sub>2</sub> was axial in ISM-B and equatorial in ISM-A and ASTM (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1</xref>), the acetylation site by the AAC(2&#x02032;) of the ASTM-group AGs turned out to be dependent on the configuration of 1-NH<sub>2</sub>. In addition, the enzyme readily acetylated ABK and DKB (Hotta et al., <xref rid="bib14" ref-type="bibr">1996a</xref>) and very slowly acetylated GM and NTL. It was remarkable that the acetylation product of ABK (2&#x02032;-<italic toggle="yes">N</italic>-acetylABK) retained clear antibiotic activity but not 2&#x02032;-<italic toggle="yes">N</italic>-acetylDKB as shown in Fig.&#x000a0;<xref rid="fig2" ref-type="fig">2</xref>. Under the conditions examined, neither ABK nor ASTM were acetylated by the AAC(2&#x02032;) of <italic toggle="yes">Providencia</italic> sp. (Kondo &#x00026; Hotta, <xref rid="bib25" ref-type="bibr">1999</xref>). FramePlot analysis (Ishikawa &#x00026; Hotta, <xref rid="bib22" ref-type="bibr">1999</xref>) following nucleotide sequencing revealed an ORF with 924&#x000a0;bp nucleotides (ATG as the start codon) that coded for a protein consisting of 307 amino acids.</p><fig position="float" id="fig2"><label>Fig. 2</label><caption><p>Difference in antibiotic activity between acetylation products of ABK and DKB by AAC(2&#x02019;) of <italic toggle="yes">S. kasugaensis</italic>. ABK, arbekacin; DKB, dibekacin; AC, acetyl.</p></caption><graphic xlink:href="kuab059fig2" position="float"/></fig></sec><sec id="sec1-3-3"><title>AAC(6&#x02032;) and AAC(1) of an actinomycete strain #8</title><p>Strain #8 was isolated from soil as an ABK-resistant actinomycete. AAC activity was detected using cell free extracts of the strain. Subsequently, we cloned a gene segment (0.9&#x000a0;kb) capable of conferring multiple resistance (Zhu et al., <xref rid="bib43" ref-type="bibr">1999</xref>) to AGs with 6&#x02032;-NH<sub>2</sub> (except for NM and ABK). Semisynthetic AGs (ABK, AMK, isepamicin [ISP] and netilmicin [NTL]) and ASTM were acetylated at 6&#x02032;-NH<sub>2</sub> (refer to Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1</xref>). This substrate specificity was not similar to those of known AAC(6&#x02032;) enzymes, but to that of AAC(6&#x02032;)-Ie known as the <italic toggle="yes">N-</italic>terminal protein of the bifunctional enzyme AAC(6&#x02032;)/APH(2&#x02032;) (Hotta &#x00026; Kondo, <xref rid="bib19" ref-type="bibr">2017</xref>). FramePlot analysis (Ishikawa &#x00026; Hotta, <xref rid="bib22" ref-type="bibr">1999</xref>) following nucleotide sequencing revealed an ORF with 495&#x000a0;bp nucleotides (ATG as the start codon) that coded for the putative AAC(6&#x02032;) consisting of 164 amino acids.</p><p>On the other hand, strain #8 was sensitive to PRM lacking 6&#x02032;-NH<sub>2</sub> and therefore PRM is free from 6&#x02032;<italic toggle="yes">-N</italic>-acetylation. However, its cell free extracts unexpectedly acetylated PRM resulting in the formation of 1-<italic toggle="yes">N</italic>-acetylPRM with remarkable antibiotic activity (Sunada et al., <xref rid="bib36" ref-type="bibr">1999</xref>), suggesting the existence of AAC(1).</p></sec></sec><sec id="sec1-4"><title>Applied Researches of AGR</title><p>Based on the unique features of AGR obtained, we carried out several application studies. Two representative studies are described.</p><sec id="sec1-4-1"><title>Indolizomycin discovery by an interspecies protoplast fusion treatment</title><p>The fact that different AG producers show different AGR patterns led us to the idea that it might be possible to generate something new if we were able to successfully create novel AGR by manipulation of AG-producing strains. Therefore, we began to challenge protoplast fusion between nonantibiotic-producing mutants of <italic toggle="yes">S. tenjimariensis</italic> SS-939 and <italic toggle="yes">S. griseus</italic> SS-1198. These have reciprocal resistance patterns in terms of resistance to KM and SM (refer to Table&#x000a0;<xref rid="tbl1" ref-type="table">1</xref>). Consequently, clones with unique profiles of resistance to AGs including KM, SM, and some other AGs were obtained and examined for antibiotic productivity. As a result, the strain SK2-52 was selected for its unique multiple AGR profile as well as its antibiotic productivity. Structure determination of the antibiotic SK2-52 produced demonstrated a novel antibiotic (Fig.&#x000a0;<xref rid="fig3" ref-type="fig">3</xref>) that was named indolizomycin (Gomi et al., <xref rid="bib4" ref-type="bibr">1984</xref>; Yamashita et al., <xref rid="bib42" ref-type="bibr">1985b</xref>). SK2-52 showed taxonomic properties of <italic toggle="yes">S. griseus</italic> but protoplast regeneration or self-fusion treatment did not provide any clone with the same properties as that of SK2-52.</p><fig position="float" id="fig3"><label>Fig. 3</label><caption><p>Structure of indolizomycin discovered by protoplast fusion treatment between <italic toggle="yes">S. tenjimariensis</italic> and <italic toggle="yes">S. griseus</italic>. ISM, istamycin; SM, streptomycin.</p><p>*ISM-A: R1&#x000a0;=&#x000a0;H, R2&#x000a0;=&#x000a0;NH<sub>2</sub>, R3&#x000a0;=&#x000a0;H, R4&#x000a0;=&#x000a0;H, R5&#x000a0;=&#x000a0;CH<sub>3</sub>, R6&#x000a0;=&#x000a0;H</p><p>*ISM-B: R1&#x000a0;=&#x000a0;NH<sub>2</sub>, R2&#x000a0;=&#x000a0;H, R3&#x000a0;=&#x000a0;H, R4&#x000a0;=&#x000a0;H, R5&#x000a0;=&#x000a0;H, R6&#x000a0;=&#x000a0;CH<sub>3</sub></p></caption><graphic xlink:href="kuab059fig3" position="float"/></fig></sec><sec id="sec1-4-2"><title>Double stage-acting activity of ABK as its unique property</title><p>AGs have been and still are playing important roles in curing various infectious diseases caused by different varieties of Gram-positive and Gram-negative bacteria. The most serious problem with the activities of AGs is resistant bacteria carrying AG-modifying (or AG-inactivating) enzymes (Hotta &#x00026; Kondo, <xref rid="bib19" ref-type="bibr">2017</xref>; Kondo &#x00026; Hotta, <xref rid="bib25" ref-type="bibr">1999</xref>). In order to overcome this problem, rationally designed semisynthetic AGs such as DKB, ABK, AMK, and ISP (Kondo &#x00026; Hotta, <xref rid="bib25" ref-type="bibr">1999</xref>) have been developed on the basis of the modification mechanisms of AG-inactivating enzymes. Among them, DKB (3&#x02032;,4&#x02032;-dideoxy-KM B) was developed and used clinically as the first rationally designed semisynthetic AG refractory to APH(3&#x02032;) and AAD(4&#x02032;). Subsequently, AMK, ABK, NTL, and ISP were developed by introducing the following side chains into their 1-<italic toggle="yes">N</italic>-position: 4-ammino-2-hydroxybutyryl (AHB) residue in AMK and ABK (refer to Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1</xref>), ethyl residue in NTL and 3-amino-2-hydroxypropionyl (AHP) residue in ISP. These side chains are believed to block the access of a variety of AG-modifying enzymes to their target sites. Hence, these AGs are refractory to various AG-modifying enzymes. However, bacteria clinically resistant to these AGs have emerged. They included MRSA strains carrying APH(3&#x02032;), AAD(4&#x02032;), and/or AAC(6&#x02032;)/APH(2&#x02032;). In such situations, ABK (1-<italic toggle="yes">N</italic>-AHB-DKB) showed remarkable activity against these MRSA strains as shown in Fig.&#x000a0;<xref rid="fig4" ref-type="fig">4</xref> and was subsequently approved in 1990 as an anti-MRSA agent (Kondo et al., <xref rid="bib24" ref-type="bibr">1991</xref>).</p><fig position="float" id="fig4"><label>Fig. 4</label><caption><p>Colony growth of MRSA (left) on Muller-Hinton agar containing 4 &#x003bc;g/ml of AG and relative activities (right) of the acetylated-AGs isolated from reaction mixtures. KM, kanamycin; GM, gentamicin; DKB, dibekacin; SISO, sisomicin; AMK, amikacin; ISP, isepamicin; ABK, arbekacin; NTL, netilmicin; ASTM, astromicin.</p></caption><graphic xlink:href="kuab059fig4" position="float"/></fig><p>Since its approval, ABK has been used clinically and further AGR MRSA strains have emerged at a low incidence. Their ABK resistance level have stayed at low or moderate level (&#x0003c;25&#x000a0;&#x003bc;g/ml) due to AAC(6&#x02032;)/APH(2&#x02032;). To the best of my knowledge, no AAC-dependent ABK-resistant MRSA strain has been reported, although the ABK molecule (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1</xref>) possessing possible modification sites at 3-NH<sub>2</sub>, 2&#x02032;-NH<sub>2</sub>, and 6&#x02032;-NH<sub>2</sub> for AAC(3), AAC(2&#x02032;), and AAC(6&#x02032;), respectively. Therefore, there remains the possibility of the eventual emergence of AAC-dependent ABK resistance. In order to confirm this possibility, we cloned genes to investigate. ABK was then challenged with the action of the AAC(3), AAC(2&#x02032;), and AAC(6&#x02032;). Consequently, it turned out that ABK was readily acetylated by all of these AACs, resulting in the formation of 3&#x02032;-<italic toggle="yes">N</italic>-acetyl-ABK, 2&#x02032;-<italic toggle="yes">N</italic>-acetyl-ABK, and 6&#x02032;-<italic toggle="yes">N</italic>-acetyl-ABK by AAC(3), AAC(2&#x02032;), and AAC(6&#x02032;), respectively (Ishikawa &#x00026;Hotta, <xref rid="bib21" ref-type="bibr">1991</xref>; Hotta et al., <xref rid="bib14" ref-type="bibr">1996</xref>a, Zhu et al., <xref rid="bib43" ref-type="bibr">1999</xref>). It was surprising to see that the former two acetylated ABKs retained remarkably high antibiotic activities (shown in Fig.&#x000a0;<xref rid="fig4" ref-type="fig">4</xref>). It was also surprising to see that AAC(3) did not acetylate ABK at 3-NH<sub>2</sub> but at 3&#x02032;-NH<sub>2</sub>. On the other hand, the 3&#x02032;-<italic toggle="yes">N</italic>-AMK and 2&#x02032;-<italic toggle="yes">N</italic>-DKB (acetylation products of AMK and DKB, respectively, by the same AAC(2&#x02032;)) showed only weak activities. Furthermore, the acetylated products by AAC(6&#x02032;) of AMK, ISP, and NTL were substantially inactive. Therefore, it turned out that ABK was distinctive from the other semisynthetic AGs in terms of the antibiotic activity of their acetylated derivatives. Thus, ABK should be regarded as a &#x0201c;double stage-acting antibiotic&#x0201d; (Hotta et al., <xref rid="bib17" ref-type="bibr">2000</xref>) that means the antibiotic capable of retaining antibiotic activity even if enzymatically modified. In addition, it was notable that the acetylation rate by AAC(6&#x02032;) of ABK was much slower than that of AMK.</p><p>Based on the above, it became possible to explain a potential mechanism as to why AAC-dependent ABK-resistant strains of MRSA hardly ever emerge even if they acquired genes of AACs. In this context, <italic toggle="yes">S. lividans</italic> TK21 carrying the cloned AAC(3) or AAC(2&#x02032;) gene was sensitive to ABK (&#x0003c;2.5&#x000a0;&#x003bc;g/ml), whereas the one carrying the cloned AAC(6&#x02032;) gene showed a weak resistance to ABK (5&#x000a0;&#x003bc;g/ml).</p><p>In spite of these results, we could not rule out the emergence of ABK resistance by acquiring two different AAC genes, since we demonstrated the enzymatic formation of diacetylated ABK derivatives (di-<italic toggle="yes">N</italic>-acetylation of NH<sub>2</sub> at 2&#x02032;/3&#x02032;, 2&#x02032;/6&#x02032; and 6&#x02032;/3&#x02032; positions) showing no antibiotic activity (Hotta, <xref rid="bib18" ref-type="bibr">2000</xref>). Therefore, we constructed <italic toggle="yes">S. lividans</italic> TK21 with two compatible plasmids each containing a different AAC gene (unpublished research). In doing so, we found that the <italic toggle="yes">S. lividans</italic> TK21 containing AAC(6&#x02032;) plus AAC(3) or AAC(2&#x02032;) genes showed resistance to ABK at 5&#x0223c;10&#x000a0;&#x003bc;g/ml whereas the strain containing both AAC(3) and AAC(2&#x02032;) genes showed no significant ABK resistance. Enzymatic acetylation using cell free extracts revealed that ABK was not readily converted to its diacetylated derivatives but to a mixture of monoacetylated and diacetylated derivatives of ABK (shown in Fig.&#x000a0;<xref rid="fig5" ref-type="fig">5</xref>) under conditions allowing for the complete monoacetylation of ABK by each AAC. Based on these findings on the acetylation of ABK by AACs, we speculate that MRSA strains will hardly ever become highly resistant to ABK even if they acquired two different AAC genes.</p><fig position="float" id="fig5"><label>Fig. 5</label><caption><p>Conversion of ABK by the action of three different AACs. I, Action of single AAC; II, Action of two mixed AACs.</p><p>Acetylation sites: 2&#x02032;/3&#x02032; = 2&#x02032;- &#x00026; 3&#x02032;-NH<sub>2</sub>, 2&#x02032;/6&#x02032; = 2&#x02032;- &#x00026; 6&#x02032;-NH<sub>2</sub>, 6&#x02032;/3&#x02032; = 6&#x02032;- &#x00026; 3&#x02032;-NH<sub>2</sub></p><p>*Relative antibiotic activity of reaction mixtures after enzymatic acetylation.</p></caption><graphic xlink:href="kuab059fig5" position="float"/></fig></sec></sec></sec><sec id="sec2"><title>Closing Remarks</title><p>Studies on multiple AGR of actinomycetes led to several new discoveries; (1) wide varieties of multiple AGR in actinomycetes, (2) isolation of a new Genus <italic toggle="yes">Crossiella</italic>, (3) correlation between individual AG resistance profiles with the productivity of intrinsic AGs in AG producers, (4) ribosomes as the self-resistance factor in <italic toggle="yes">S. tenjimariensis</italic> SS-939, (5) additional AG resistance (nonself-resistance) factors, AACs [AAC(3), AAC(2&#x02032;), and AAC(6&#x02032;)] with novel substrate specificities, (6) activation of a cryptic AAC(3) gene by one base substitution of the -10 promoter sequence, and (7) double stage-acting activity of ABK.</p><p>These findings might allow the author to insist that actinomycetes with novel profiles of multiple AGR will be an eventual treasure chest of &#x0201c;something new&#x0201d; and that &#x0201c;double stage-acting activity&#x0201d; found in ABK will become a new concept for developing new future AGs. Furthermore, our findings may lead to additional future research as shown in the case of the discovery of ribosomal AG resistance that was linked to the sequential molecular basis analysis of AGR of actinomycetes producing ASTM group AGs by other research groups (<xref rid="bib28" ref-type="bibr">Ohta et al., 1993</xref>; Piendl et al., <xref rid="bib31" ref-type="bibr">1984</xref>; Skeggs et al., <xref rid="bib35" ref-type="bibr">1985</xref>).</p></sec></body><back><ack id="ack1"><title>Acknowledgments</title><p>The author is grateful to J. Ishikawa, C.-B. Zhu, A. Sunada, K. Ishino, N. Tsuchizaki, H. Yamamoto, A. Takahashi, N. Saito, T. Shigyo, M. Morioka, Y. Ikeda, H. Naganawa, S. Kondo, and Y. Okami for collaboration. Special thanks go to Dr. H. Osada for giving the author the opportunity to write this article, and Drs. M. Yagisawa and P. Foster for their encouragement and valuable help.</p><p>This article is dedicated to the late Dr. A.L. Demain, a worldwide distinguished microbiologist who passed away on April 3, 2020 of COVID-19. It is dedicated in recognition and appreciation of his friendship, professional activities and contributions to actinomycete researches. There is no doubt that Arny educated, encouraged, and inspired many Japanese actinomycete researchers. The Society of Actinomycetes Japan recognized him an honorary member in 1995 and held a special symposium to celebrate his 80<sup>th</sup> birthday in 2007. The author was inspired by Professor Demain's review papers, especially ones relating to antibiotic resistance. In this article, therefore, the author has outlined his original research achievements on multiple AG resistance of actinomycetes.</p></ack><sec id="sec3"><title>Funding</title><p>None declared.</p></sec><sec id="sec4"><title>Conflict of Interest</title><p>The author declares no conflict of interest.</p></sec><ref-list id="ref1"><title>References</title><ref id="bib1"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Benveniste</surname>
<given-names>R.</given-names>
</string-name>, <string-name><surname>Davies</surname><given-names>J. E.</given-names></string-name></person-group> (<year>1973</year>). <article-title>Aminoglycoside antibiotic -inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>70</volume>(<issue>8</issue>), <fpage>2276</fpage>&#x02013;<lpage>2280</lpage>.</mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cundliffe</surname>
<given-names>E.</given-names>
</string-name>
</person-group> (<year>1989</year>). <article-title>How antibiotic-producing organisms avoide suicide</article-title>. <source>Annual Review of Microbiology</source>, <volume>43</volume>(<issue>1</issue>), <fpage>207</fpage>&#x02013;<lpage>233</lpage>.</mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Demain</surname>
<given-names>A. L.</given-names>
</string-name>
</person-group> (<year>1974</year>). <article-title>How do antibiotic-producing microorganisms avoid suicide?</article-title><source>Annals of the New York Academy of Sciences</source>, <volume>235</volume>, <fpage>601</fpage>&#x02013;<lpage>612</lpage>.<pub-id pub-id-type="pmid">4604540</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gomi</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Ikeda</surname><given-names>D.</given-names></string-name>, <string-name><surname>Nakamura</surname><given-names>H.</given-names></string-name>, <string-name><surname>Naganawa</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yamashita</surname><given-names>F.</given-names></string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name>, <string-name><surname>Iitaka</surname><given-names>Y.</given-names></string-name></person-group> (<year>1984</year>). <article-title>Isolation and structure of a new antibiotic, indolizomycin, produced by a strain SK2-52 obtained by interspecies fusion treatment</article-title>. <source>The Journal of Antibiotics</source>, <volume>37</volume>(<issue>11</issue>), <fpage>1491</fpage>&#x02013;<lpage>1494</lpage>.<pub-id pub-id-type="pmid">6549003</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name></person-group> (<year>1976</year>). <article-title>Effect of Mg<sup>++</sup> on binding of aminoglycoside antibiotic to their producers</article-title>. <source>Journal of Fermentation Technology</source>, <volume>54</volume>, <fpage>563</fpage>&#x02013;<lpage>571</lpage>.</mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Saito</surname><given-names>N.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name></person-group> (<year>1980</year>). <article-title>Studies on new aminoglycoside isolated from a marine environment. I. The use of plasmid profiles in screening antibiotic-producing streptomycetes</article-title>. <source>The Journal of Antibiotics</source>, <volume>33</volume>(<issue>12</issue>), <fpage>1502</fpage>&#x02013;<lpage>1509</lpage>.<pub-id pub-id-type="pmid">7251490</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Yamamoto</surname><given-names>H.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1981</year>). <article-title>Resistance mechanisms of kanamycin-, neomycin-, and streptomycin-producing streptomycetes to aminoglycoside antibiotics</article-title>. <source>The Journal of Antibiotics</source>, <volume>34</volume>(<issue>9</issue>), <fpage>1175</fpage>&#x02013;<lpage>1182</lpage>.<pub-id pub-id-type="pmid">7328057</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Takahashi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Saito</surname><given-names>N.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1983a</year>). <article-title>Multiple resistance to aminoglycoside antibiotics in actinomycetes</article-title>. <source>The Journal of Antibiotics</source>, <volume>36</volume>(<issue>12</issue>), <fpage>1748</fpage>&#x02013;<lpage>1754</lpage><pub-id pub-id-type="pmid">6662815</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Takahashi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1983b</year>). <article-title>Relationship between antibiotic resistance and antibiotic productivity in actinomycetes which produce aminoglycoside antibiotics</article-title>. <source>The Journal of Antibiotics</source>, <volume>36</volume>(<issue>12</issue>), <fpage>1789</fpage>&#x02013;<lpage>1791</lpage>.<pub-id pub-id-type="pmid">6662822</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ichihara</surname><given-names>M.</given-names></string-name>, <string-name><surname>Naganawa</surname><given-names>H.</given-names></string-name>, <string-name><surname>Mizuno</surname><given-names>S.</given-names></string-name></person-group> (<year>1988</year>). <article-title>Mechanism of increased kanamycin resistance generated by protoplast regeneration of <italic toggle="yes">Streptomyces griseus</italic> I. Cloning of a gene segment directing a high level of an aminoglycoside 3-N-acetyltransferase activity</article-title>. <source>The Journal of Antibiotics</source>, <volume>41</volume>(<issue>1</issue>), <fpage>94</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">3126171</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ogata</surname><given-names>T.</given-names></string-name>, <string-name><surname>Mizuno</surname><given-names>S.</given-names></string-name></person-group> (<year>1992</year>). <article-title>Secondary aminoglycoside resistance in aminoglycoside-producing strains of <italic toggle="yes">Streptomyces</italic></article-title>. <source>Gene</source>, <volume>115</volume>(<issue>1-2</issue>), <fpage>113</fpage>&#x02013;<lpage>117</lpage>.<pub-id pub-id-type="pmid">1612424</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Davies</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yagisawa</surname><given-names>M.</given-names></string-name></person-group> (<year>1995</year>). In <person-group person-group-type="editor"><string-name><surname>Vining</surname><given-names>L. C.</given-names></string-name>, <string-name><surname>Stuttard</surname><given-names>C.</given-names></string-name></person-group> (Eds.), <source>Genetics and biochemistry of antibiotic production</source> (pp. <fpage>571&#x02013;596)</fpage>. <publisher-loc>Butterworth-Heinemann</publisher-loc>.</mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name></person-group> (<year>1996</year>). <article-title>Diversity in aminoglycoside antibiotic resistance of actinomycetes and its exploitation in the search for novel antibiotics</article-title>. <source>Journal of Industrial Microbiology</source>, <volume>17</volume>, <fpage>352</fpage>&#x02013;<lpage>358</lpage>.</mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Zhu</surname><given-names>C.-B.</given-names></string-name>, <string-name><surname>Ogata</surname><given-names>T.</given-names></string-name>, <string-name><surname>Sunada</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mizuno</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ikeda</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>S.</given-names></string-name></person-group> (<year>1996a</year>). <article-title>Enzymatic 2&#x02032;-N-acetylation of arbekacin and antibiotic activity of its product</article-title>. <source>The Journal of Antibiotics</source>, <volume>49</volume>(<issue>5</issue>), <fpage>458</fpage>&#x02013;<lpage>464</lpage>.<pub-id pub-id-type="pmid">8682723</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Ogata</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Okanishi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mizuno</surname><given-names>S.</given-names></string-name>, <string-name><surname>Morioka</surname><given-names>M</given-names></string-name>, <string-name><surname>Naganawa</surname><given-names>H.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name></person-group> (<year>1996b</year>). <article-title>Mechanism of multiple aminoglycoside resistance of kasugamycin-producing <italic toggle="yes">Streptomyces kasugaensis</italic> MB273: Involvement of a two types of acetyltransferases in resistance to astromicin group antibiotics</article-title>. <source>The Journal of Antibiotics</source>, <volume>49</volume>(<issue>7</issue>), <fpage>682</fpage>&#x02013;<lpage>688</lpage>.<pub-id pub-id-type="pmid">8784431</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Sunada</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mizuno</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ikeda</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>S.</given-names></string-name></person-group> (<year>1998</year>). <article-title>The novel enzymatic 3&#x02033;-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of <italic toggle="yes">Streptomyces</italic> origin and the resulting activity</article-title>. <source>The Journal of Antibiotics</source><volume>51</volume>(<issue>8</issue>), <fpage>735</fpage>&#x02013;<lpage>742</lpage>.<pub-id pub-id-type="pmid">9766465</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Sunada</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ikeda</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>S.</given-names></string-name></person-group> (<year>2000</year>). <article-title>Double stage activity in aminoglycoside antibiotics</article-title>. <source>The Journal of Antibiotics</source>, <volume>53</volume>(<issue>10</issue>), <fpage>1168</fpage>&#x02013;<lpage>1174</lpage>.<pub-id pub-id-type="pmid">11132963</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>
</person-group> (<year>2000</year>). <source>Predictive studies, using antibiotic-inactivating enzymes of antibiotic producers, on the umergence of arbekacin (an anti-MRSA agent) resistant strains</source>. <publisher-name>The Waksman Foundation of Japan Inc</publisher-name>. <comment>Research Report (1985-1999)</comment>, pp.<fpage>280</fpage>&#x02013;<lpage>282</lpage>.</mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hotta</surname>
<given-names>K.</given-names>
</string-name>, <string-name><surname>Kondo</surname><given-names>S.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Kanamycin and its derivative, arbekacin: significance and impact</article-title>. <source>The Journal of Antibiotics</source>, <volume>71</volume>(<issue>4</issue>), <fpage>417</fpage>&#x02013;<lpage>424</lpage>.</mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ishikawa</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Koyama</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Mizuno</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name></person-group> (<year>1988</year>). <article-title>Mechanism of increased kanamycin resistance generated by protoplast regeneration of <italic toggle="yes">Streptomyces griseus</italic>. II. Mutational gene alteration and gene amplification as genetic mechanisms</article-title>. <source>The Journal of Antibiotics</source>, <volume>41</volume>(<issue>1</issue>), <fpage>104</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">3126169</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ishikawa</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name></person-group> (<year>1991</year>). <article-title>Nucleotide sequence and transcriptional start point of the <italic toggle="yes">kan</italic> gene encoding an aminoglycoside 3-N-acetyltransferase from <italic toggle="yes">Streptomyces griseus</italic> SS-1198PR</article-title>. <source>Gene</source>, <volume>108</volume>, <fpage>127</fpage>&#x02013;<lpage>132</lpage>.<pub-id pub-id-type="pmid">1761222</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ishikawa</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K</given-names></string-name></person-group>. (<year>1999</year>). <article-title>FramePlot: a new implementation of the Frame analysis for predicting protein-coding regions in bacterial DNA with a high G+C content</article-title>. <source>FEMS Microbiology Letters</source><volume>174</volume>(<issue>2</issue>), <fpage>251</fpage>&#x02013;<lpage>253</lpage>.<pub-id pub-id-type="pmid">10339816</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ishikawa</surname>
<given-names>J.</given-names>
</string-name>, <string-name><surname>Sunada</surname><given-names>A.</given-names></string-name>, <string-name><surname>Oyama</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name></person-group> (<year>2000</year>). <article-title>Identification and characterization of the point mutation which affects transcription level of chromosomal 3-N-acetyltransferase gene in <italic toggle="yes">Streptomyces griseus</italic> SS-1198</article-title>. <source>Antimicrobial Agents and Chemotherapy</source>, <volume>44</volume>(<issue>2</issue>), <fpage>437</fpage>&#x02013;<lpage>440</lpage>.<pub-id pub-id-type="pmid">10639379</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kondo</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Ikeda</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hattori</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hamada</surname><given-names>M.</given-names></string-name>, <string-name><surname>Takeuchi</surname><given-names>T.</given-names></string-name></person-group> (<year>1991</year>). <article-title>Susceptibility of methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> to various antibiotics: Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA</article-title>. <source>The Japanese Journal of Antibiotics (Japanese)</source>, <volume>44</volume>, <fpage>1211</fpage>&#x02013;<lpage>1215</lpage>.</mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kondo</surname>
<given-names>S.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name></person-group> (<year>1999</year>). <article-title>Semisynthetic aminoglycoside antibiotics: Development and enzymatic modification</article-title>. <source>Journal of Infection and Chemotherapy</source><volume>5</volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">11810483</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Labeda</surname>
<given-names>D. P.</given-names>
</string-name>
</person-group> (<year>2001</year>). <article-title><italic toggle="yes">Crossiella</italic> gen.nov., a new genus related to <italic toggle="yes">Streptoalloteocus</italic></article-title>. <source>International Journal of Systematic and Evolutionary Microbiology</source><volume>51</volume>(<issue>4</issue>), <fpage>1575</fpage>&#x02013;<lpage>1579</lpage>.<pub-id pub-id-type="pmid">11491360</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nara</surname>
<given-names>T.</given-names>
</string-name>, <string-name><surname>Yamamoto</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kawamoto</surname><given-names>I.</given-names></string-name>, <string-name><surname>Takayama</surname><given-names>K.</given-names></string-name>, <string-name><surname>Okachi</surname><given-names>R.</given-names></string-name>, <string-name><surname>Takasawa</surname><given-names>S.</given-names></string-name>, <string-name><surname>Sano</surname><given-names>S.</given-names></string-name></person-group> (<year>1977</year>). <article-title>Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organisms, fermentation and biological properties of fortimicin</article-title>. <source>The Journal of Antibiotics</source>, <volume>30</volume>(<issue>7</issue>), <fpage>533</fpage>&#x02013;<lpage>540</lpage>.<pub-id pub-id-type="pmid">893224</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ohta</surname>
<given-names>T.</given-names>
</string-name>, <string-name><surname>Dairi</surname><given-names>T.</given-names></string-name>, <string-name><surname>Hasegawa</surname><given-names>M.</given-names></string-name></person-group> (<year>1993</year>). <article-title>Characterization of two different types of resistance genes among producers of fortimicin-group antibiotics</article-title>. <source>Journal of General Microbiology</source>, <volume>139</volume>(<issue>3</issue>), <fpage>591</fpage>&#x02013;<lpage>599</lpage>.<pub-id pub-id-type="pmid">8473864</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Okami</surname>
<given-names>Y.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Yoshida</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ikeda</surname><given-names>D.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1979</year>). <article-title>New aminoglycoside antibiotics, istamycins A and B</article-title>. <source>The Journal of Antibiotics</source>, <volume>32</volume>(<issue>9</issue>), <fpage>964</fpage>&#x02013;<lpage>966</lpage>.<pub-id pub-id-type="pmid">511787</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Okanishi</surname>
<given-names>M.</given-names>
</string-name>
</person-group> (<year>1979</year>). <article-title>Plasmids and antibiotic synthesis in streptomycetes</article-title>. In <person-group person-group-type="editor"><string-name><surname>Sabek</surname><given-names>O. K.</given-names></string-name>, <string-name><surname>Laskin</surname><given-names>A. I.</given-names></string-name></person-group> (Eds.), <source>Genetics of industrial microorganisms</source> (pp. <fpage>134</fpage>&#x02013;<lpage>140</lpage>). <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Society of Microbiol</publisher-name>ogy.</mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Piendl</surname>
<given-names>W.</given-names>
</string-name>, <string-name><surname>Boeck</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cundiffe</surname><given-names>E.</given-names></string-name></person-group> (<year>1984</year>). <article-title>Involvement of 16S rRNA in resistance of the aminoglycoside-producers <italic toggle="yes">Streptomyces tenjimariensis, Streptomyces tenebrarius</italic> and <italic toggle="yes">Micromonospora purpurea</italic></article-title>. <source>Molecular and General Genetics MGG</source><volume>197</volume>(<issue>1</issue>), <fpage>24</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">6083433</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Piepersberg</surname>
<given-names>W.</given-names>
</string-name>, <string-name><surname>Distler</surname><given-names>J.</given-names></string-name></person-group> (<year>1997</year>). <article-title>Aminoglycosides and sugar components in other secondary metabolites</article-title>. In <person-group person-group-type="editor"><string-name><surname>Rehm</surname><given-names>H. J.</given-names></string-name>, <string-name><surname>Reed</surname><given-names>G.</given-names></string-name></person-group> (Eds.), <comment>Biotechnology</comment>. Vol. <volume>7</volume>: <source>Products of secondary metabolism</source> (<comment>Kleinkauf K., von Dohren H.</comment>, <comment>Volume Eds.</comment>, pp. <fpage>397</fpage>&#x02013;<lpage>488</lpage>). <publisher-loc>Weinheim</publisher-loc>: <publisher-name>VCH-Verlagsgesellschaft</publisher-name>.</mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Shaw</surname>
<given-names>K. J.</given-names>
</string-name>, <string-name><surname>Rather</surname><given-names>P. N.</given-names></string-name>, <string-name><surname>Hare</surname><given-names>R</given-names></string-name>, <string-name><surname>Miller</surname><given-names>G</given-names></string-name></person-group>. (<year>1993</year>). <article-title>Molecular genetics of aminoglycoside resistance genes and familial relationship of aminoglycoside-modifying enzymes</article-title>. <source>Microbiological Reviews</source><volume>57</volume>(<issue>1</issue>), <fpage>138</fpage>&#x02013;<lpage>163</lpage>.<pub-id pub-id-type="pmid">8385262</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Shigyo</surname>
<given-names>T.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1984</year>). <article-title>Plasmid variability in the istamycin producing strains of <italic toggle="yes">Streptomycejimariensis</italic></article-title>. <source>The Journal of Antibiotics</source><volume>37</volume>(<issue>6</issue>), <fpage>635</fpage>&#x02013;<lpage>640</lpage>.<pub-id pub-id-type="pmid">6086558</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Skeggs</surname>
<given-names>P.A.</given-names>
</string-name>, <string-name><surname>Thompson</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cundliffe</surname><given-names>E.</given-names></string-name></person-group> (<year>1985</year>). <article-title>Methylation of 16S ribosomal RNA and resistance to aminoglycoside antibiotics in clones of <italic toggle="yes">Streptomyces lividans</italic> carrying DNA from <italic toggle="yes">Streptomyces tenjimariensis</italic></article-title>. <source>Molecular and General Genetics MGG</source><volume>200</volume>(<issue>3</issue>), <fpage>415</fpage>&#x02013;<lpage>421</lpage>.<pub-id pub-id-type="pmid">3862930</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sunada</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Nakajima</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ikeda</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name></person-group> (<year>1999</year>). <article-title>Enzymatic 1-N-acetylation of paromomycin by an actinomycete strain #8 with multiple aminoglycoside resistance and paromomycinsensitivity</article-title>. <italic toggle="yes">The</italic><source>Journal of Antibiotics</source>, <volume>52</volume>, <fpage>809</fpage>&#x02013;<lpage>814</lpage>.</mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Takahashi</surname>
<given-names>A.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Saito</surname><given-names>N.</given-names></string-name>, <string-name><surname>Morioka</surname><given-names>M.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1986</year>). <article-title>Production of novel antibiotic, dopsisamine, by a new subspecies of <italic toggle="yes">Nocardiopsis mutabilis</italic> with multiple antibiotic resistance</article-title>. <source>The Journal of Antibiotics</source>, <volume>39</volume>(<issue>2</issue>), <fpage>175</fpage>&#x02013;<lpage>183</lpage>.<pub-id pub-id-type="pmid">3754250</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamamoto</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1981a</year>). <article-title>Self-resistance of a <italic toggle="yes">Streptomyces</italic> which produces istamycins</article-title>. <source>The Journal of Antibiotics</source>, <volume>34</volume>(<issue>7</issue>), <fpage>824</fpage>&#x02013;<lpage>829</lpage>.<pub-id pub-id-type="pmid">7026523</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamamoto</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1981b</year>). <article-title>Ribosomal resistance of an istamycin producer. <italic toggle="yes">Streptomyces tenjimariensis</italic>, to aminoglycoside antibiotics</article-title>. <source>Biochemical and Biophysical Research Communications</source>, <volume>100</volume>(<issue>3</issue>), <fpage>1396</fpage>&#x02013;<lpage>1401</lpage>.<pub-id pub-id-type="pmid">7271807</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamamoto</surname>
<given-names>H.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1982</year>). <article-title>Mechanism of resistance to aminoglycoside antibiotics in nebramysin-producing <italic toggle="yes">Streptomyces tenebrarius</italic></article-title>. <source>The Journal of Antibiotics</source>, <volume>35</volume>(<issue>8</issue>), <fpage>1020</fpage>&#x02013;<lpage>1025</lpage>.<pub-id pub-id-type="pmid">7142002</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamashita</surname>
<given-names>F.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kurasawa</surname><given-names>S.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1985a</year>). <article-title>New antibiotic-producing streptomycetes selected by antibiotic production generated by protoplast fusion treatment between <italic toggle="yes">Streptomyces griseus</italic> and <italic toggle="yes">S. tenjimariensis</italic></article-title>. <source>The Journal of Antibiotics</source>, <volume>38</volume>(<issue>1</issue>), <fpage>58</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">3972729</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yamashita</surname>
<given-names>F.</given-names>
</string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name>, <string-name><surname>Okami</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Umezawa</surname><given-names>H.</given-names></string-name></person-group> (<year>1985b</year>). <article-title>The generation of additional antibiotic resistance by protoplast regeneration of a <italic toggle="yes">Streptomyces</italic> strain</article-title>. <source>The Journal of Antibiotics</source>, <volume>38</volume>(<issue>1</issue>), <fpage>126</fpage>&#x02013;<lpage>127</lpage>.<pub-id pub-id-type="pmid">3972723</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhu</surname>
<given-names>C.-B.</given-names>
</string-name>, <string-name><surname>Sunada</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ishikawa</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ikeda</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hotta</surname><given-names>K.</given-names></string-name></person-group> (<year>1999</year>). <article-title>Role of aminoglycoside 6&#x02032;-acetyltranferase in a novel multiple resistance of an actinomycete strain #8: inactivation of aminoglycoside with 6&#x02032;-amino group except arbekacin and neomycin</article-title>. <source>The Journal of Antibiotics</source>, <volume>52</volume>, <fpage>889</fpage>&#x02013;<lpage>894</lpage>.<pub-id pub-id-type="pmid">10604758</pub-id></mixed-citation></ref></ref-list></back></article>